BRIGATINIB for Disease progression: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where BRIGATINIB was used for Disease progression.
Most Reported Side Effects for BRIGATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 405 | 12.3% | 404 | 70 |
| Non-small cell lung cancer | 370 | 11.3% | 69 | 63 |
| Off label use | 256 | 7.8% | 64 | 73 |
| Diarrhoea | 239 | 7.3% | 29 | 91 |
| Metastases to central nervous system | 219 | 6.7% | 33 | 40 |
| Nausea | 218 | 6.6% | 24 | 89 |
| Lung neoplasm malignant | 216 | 6.6% | 38 | 36 |
| Fatigue | 201 | 6.1% | 26 | 61 |
| Blood creatine phosphokinase increased | 198 | 6.0% | 10 | 42 |
| Product dose omission issue | 193 | 5.9% | 18 | 70 |
| Neoplasm progression | 172 | 5.2% | 32 | 24 |
| Drug ineffective | 171 | 5.2% | 33 | 31 |
| Vomiting | 122 | 3.7% | 23 | 47 |
| Dyspnoea | 121 | 3.7% | 21 | 52 |
| Cough | 112 | 3.4% | 19 | 37 |
Other Indications for BRIGATINIB
Non-small cell lung cancer (1,130)
Lung neoplasm malignant (946)
Product used for unknown indication (513)
Lung adenocarcinoma (148)
Non-small cell lung cancer metastatic (82)
Neurofibromatosis (70)
Lung adenocarcinoma stage iv (60)
Neoplasm malignant (39)
Bronchial carcinoma (30)
Lung cancer metastatic (30)
Other Drugs Used for Disease progression
CAPECITABINE (57)
DEXAMETHASONE (53)
CYCLOPHOSPHAMIDE (52)
RITUXIMAB (52)
IRINOTECAN (50)
CARBOPLATIN (48)
IFOSFAMIDE (44)
CISPLATIN (41)
ETOPOSIDE (39)
PREDNISONE (39)